KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Accounts Payables: 2020-2024

Historic Accounts Payables for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Dec 2024 value amounting to $14.2 million.

  • Ginkgo Bioworks Holdings' Accounts Payables fell 31.82% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year decrease of 31.82%. This contributed to the annual value of $14.2 million for FY2024, which is 51.98% up from last year.
  • As of FY2024, Ginkgo Bioworks Holdings' Accounts Payables stood at $14.2 million, which was up 51.98% from $9.3 million recorded in FY2023.
  • Ginkgo Bioworks Holdings' 5-year Accounts Payables high stood at $14.2 million for FY2024, and its period low was $8.2 million during FY2021.
  • Its 3-year average for Accounts Payables is $11.3 million, with a median of $10.5 million in 2022.
  • In the last 5 years, Ginkgo Bioworks Holdings' Accounts Payables plummeted by 41.06% in 2021 and then soared by 51.98% in 2024.
  • Yearly analysis of 5 years shows Ginkgo Bioworks Holdings' Accounts Payables stood at $13.9 million in 2020, then crashed by 41.06% to $8.2 million in 2021, then increased by 27.62% to $10.5 million in 2022, then dropped by 10.79% to $9.3 million in 2023, then skyrocketed by 51.98% to $14.2 million in 2024.